Endocrine Abstracts

Contents

• Oral Presentations
• • Oral Session 1: Topic Highlights
  • • Cryo-electron microscopy structure of full length TSH receptor in complex with TSH receptor blocking human monoclonal autoantibody K1-70TM

      ea0084op-01-01
    • A randomized, double-blind, placebo-controlled trial of Vitamin D supplementation in patients newly diagnosed with graves' disease

      ea0084op-01-02
    • The relationship between thyroid function and lipid metabolomics and response to combination thyroid hormone replacement

      ea0084op-01-03
    • Selenoprotein deficiency disorder predisposes to aortic aneurysm formation

      ea0084op-01-04
    • Sarcopenia as a prognostic factor in patients with advanced thyroid cancer treated with tyrosine kinase inhibitors

      ea0084op-01-05
    • Modeling braf-induced thyroid cancer development and cell redifferentiation using pluripotent stem cell-derived organoids

      ea0084op-01-06
  • Oral Session 2: Pregnancy
  • • Use of levothyroxine for euthyroid women with positive thyroid antibodies and infertility: Results of thesis (treatment of hypothyroidism in europe by specialists: an international survey)

      ea0084op-02-07
    • Real world study on the impact of thyroid hormone treatment on pregnancy outcomes in women with subclinical hypothyroidism without tpoab

      ea0084op-02-08
    • Hypothyroidism and the risk of preeclampsia: A national and regional study of 1,014,775 pregnancies in denmark

      ea0084op-02-09
    • Phthalate exposure is associated with thyroid function during pregnancy through a novel pathway as a hcg disruptor

      ea0084op-02-10
    • Association of thyroid function and tpoab positivity with the risk of postpartum depression: A population-based cohort study, systematic review, and meta-analysis

      ea0084op-02-11
  • Oral Session 3: Advanced Thyroid Cancer
  • • Clinicopathological and epidemiological features of thyroid cancer patients intended to initiate systemic therapy

      ea0084op-03-12
    • Thyroid cancer relapse as a challenge to a surgeon: The efficacy of radioguided occult lesion localization (roll) technique

      ea0084op-03-13
    • Entrectinib in patients with ntrk fusion-positive (ntrk-fp) thyroid cancer: Updated data from startrk-2

      ea0084op-03-14
    • Assessment of adrenal function in a large series of patients confirms that adrenal insufficiency is a common cause of fatigue during treatment with multikinase inhibitors (MKIS)

      ea0084op-03-15
    • A clinical and molecular study of a real-world cohort of braf v600e anaplastic thyroid carcinoma treated with dabrafenib and trametinib

      ea0084op-03-16
  • Oral Session 4: Basic 1
  • • Age and diet regulate intrahepatic thyroid hormone concentration in a mouse model of non-alcoholic fatty liver disease (NAFLD)

      ea0084op-04-17
    • Differential impact of intrathyroidal IL-4 expression on thyroiditis development in C57BL/6J and NOD.H2H4 THYR-IL4 mice

      ea0084op-04-18
    • A thyroid hormone-independent role for transthyretin in neural stem cells of the postnatal mouse subventricular zone?

      ea0084op-04-19
    • Rewiring of liver diurnal transcriptome rhythms by triiodothyronine (T3) supplementation

      ea0084op-04-20
    • CRYO-electron microscopy structures of human thyroid peroxidase (TPO) in complex with tpo antibodies

      ea0084op-04-21
  • Oral Session 5: Autoimmunity
  • • Update on the role of caveolin-1 in cell homeostasis and oxidative stress in hashimoto's thyroiditis and graves' disease

      ea0084op-05-22
    • Cut-offs for thyroid peroxidase and thyroglobulin antibodies in early pregnancy are not similar and may differ from non-pregnant individuals: evidence from 10,905 danish pregnant women

      ea0084op-05-23
    • Sirolimus for graves' orbitopathy: A novel drug for the management of patients with moderate-to-severe graves' orbitopathy?

      ea0084op-05-24
    • Intestinal barrier permeability in patients with hashimoto's thyroiditis associated to non-endocrine autoimmune disorders

      ea0084op-05-25
    • Prospective single blind, usa-based, multicenter comparison of tsh-receptor antibody immunoassays

      ea0084op-05-26
  • Oral Session 6: Hypothyroidism
  • • Evaluation of dried blood spot thyroglobulin as a biomarker for iodine status in pregnant women and newborns

      ea0084op-06-27
    • The optimal ranges of thyroid function based on the risk of cardiovascular disease and mortality: an individual participant data meta-analysis

      ea0084op-06-28
    • Central hypothyroidism ensuing endonasal transsphenoidal pituitary surgery: the role of a post operative trh stimulation test

      ea0084op-06-29
    • Levothyroxine replacement therapy overuse and factors guiding successful treatment discontinuation: short and long-term observation data of a large cohort

      ea0084op-06-30
    • Does subclinical hypothyroidism add on any symptoms? evidence from a danish population-based study

      ea0084op-06-31
  • Oral Session 7: Thyroid Cancer Basic
  • • The micro-rna content of extracellular vesicles in papillary thyroid cancer: from identification in mouse thyroid tumour to detection in patient plasma

      ea0084op-07-32
    • HuRthle cell tumors vs oncocytic variants of the follicular cell derived thyroid tumours: a comprehensive analysis based in transcriptome, proteome and cnv profiling

      ea0084op-07-33
    • CDK4 phosphorylation status and rational use of CDK4/6 inhibitors in advanced thyroid cancers

      ea0084op-07-34
    • RET fusion genes in a large cohort of papillary thyroid carcinomas

      ea0084op-07-35
    • Loss of tumor cell MHC class ii expression as driver of relapse to dabrafenib and trametinib in mouse BRAF-mutant anaplastic thyroid cancer

      ea0084op-07-36
  • Oral Session 8: Basic 2
  • • Resistance to thyroid hormone alpha: molecular, biochemical and physiological approach to diagnosis and therapy

      ea0084op-08-37
    • Brain effects of combined levothyroxine (T4) and 3-iodothyronamine (T1AM) replacement therapy in a murine model of hypothyroidism

      ea0084op-08-38
    • Stochastic epigenetic mutations as possible explanation for phenotypical discordance among twins with congenital hypothyroidism

      ea0084op-08-39
    • Disrupted trans-placental thyroid hormone transport in a human model for MCT8 deficiency

      ea0084op-08-40
    • BOREALIN/CDCA8 is necessary for an adequate thyroid morphogenesis and aging

      ea0084op-08-41
  • Oral Session 9: Thyroid Cancer Clinical
  • • Childhood papillary thyroid carcinoma: long-term postoperative outcome and prediction of recurrent disease in 189 patients consecutively treated at the mayo clinic during 1936 through 2020

      ea0084op-09-42
    • Novel somatic mutations in sporadic MTC (spMTC); clinical utility of NGS in precision medicine

      ea0084op-09-43
    • Dynamic risk stratification in long-term clinical outcome of papillary thyroid cancer patients

      ea0084op-09-44
    • The phenotype correlated with RET V804 germline mutation is characterized by the presence of medullary thyroid cancer alone

      ea0084op-09-45
    • Interim outcome analysis of prospective ATA recurrence risk (RR) stratification for postoperative treatment and follow up of differentiated thyroid cancer (DTC)

      ea0084op-09-46
  • Oral Session 10: Young Investigators / Clinical and Translational
  • • Putative protective role of anti-nuclear antibodies in graves' orbitopathy

      ea0084op-10-47
    • Abstract unavailable

      ea0084op-10-48
    • TSH-receptor antibodies among 1,024 early pregnant women in the north denmark region: cut-off, prevalence, and follow-up

      ea0084op-10-49
    • Outcomes of lenvatinib therapy in poorly differentiated thyroid carcinoma

      ea0084op-10-50
    • Hypocalcemia is a frequent and life-threatening effect during lenvatinib treatment

      ea0084op-10-51
    • Outcome of sporadic medullary thyroid cancer (MTC) patients with a biochemical persistent disease after initial treatment

      ea0084op-10-52
  • Oral Session 11: Young Investigators / Basic
  • • CD3+CD8+CD20+ T cells as a marker of the inflammatory phase in thyroid autoimmune and related polyautoimmune disorders: a pilot study

      ea0084op-11-53
    • Study of target tissue-resident immune cells in graves' disease and orbitopathy (star-GO): preliminary findings with a novel extensive immunophenotyping panel

      ea0084op-11-54
    • Role of NADPH oxidase 4 (NOX4) in resistance to metabolic iodine-131 radiotherapy in metastatic thyroid tumors carrying the BRAFV600E mutation

      ea0084op-11-55
    • Focusing on the role of the enigmatic TR[alpha]2 isoform in modulation of thyroid hormone action

      ea0084op-11-56
    • Monocarboxylate 8 transporter and deiodinase 2 deficiency impairs neurogliogesis in the adult mouse subventricular zone leading to cellular and functional alterations

      ea0084op-11-57
    • Integrated genomic, phenomic, functional and structural mapping of variants in thyroid hormone transporter MCT8

      ea0084op-11-58
  • Oral Session 12: Nodules and Diagnostic
  • • Autonomously functioning thyroid nodules present intermediate malignancy risk according to european thyroid imaging and reporting data system; a comprehensive clinical, cytological and molecular characterization

      ea0084op-12-59
    • Population study on thyroid nodule ultrasound (TUS) reports quality with adherence to guidelines

      ea0084op-12-60
    • Comparison of accuracy of 18F-fluorocholine PET-CT and PET/MR to 99MTC-sestamibi for the localization of hyperfunctioning parathyroid tissue in hyperparathyroidism

      ea0084op-12-61
    • Progressive diastolic dysfunction in survivors of pediatric differentiated thyroid carcinoma

      ea0084op-12-62
    • Real-world performance of a novel dual-component molecular assay in cytologically indeterminate thyroid nodules: a single institutional experience

      ea0084op-12-63
  • Oral Session 13: Basic 3
  • • Metabolic and neuroinflammatory consequences of hypothyroidism in two mouse strains with different metabolic adaptability capacities, the C57BL/6J and the WSB/EIJ strains

      ea0084op-13-64
    • 3,3',5-triiodo-l-thyronine and 3,5-diodo-l-thyronine differentially modulate hepatic mitochondrial quality control in hypothyroid rats

      ea0084op-13-65
    • Generation of human thyroid organoids from embryonic stem cells to rescue hypothyroidism

      ea0084op-13-66
    • A single cell atlas of the T3-responsive transcriptome during early cortical neurogenesis in human cerebral organoids

      ea0084op-13-67
    • Abstract unavailable

      ea0084op-13-68
• Poster Presentations
• • COVID & Thyroid Disease
  • • Autoimmune and inflammatory thyroid diseases following SARS-CoV-2 vaccines: an update from a systematic review of the literature

      ea0084ps1-01-01
    • Post covid-19 complication in patient with chronic autoimmune thyroiditis

      ea0084ps1-01-02
    • Incidence of subacute thyroiditis and autoimmune thyroid disease during COVID-19 pandemic

      ea0084ps1-01-03
    • Subacute thyroiditis: The severity depends on the causative agent and the treatment requires a lower glucocorticoid dose than that recommended by the guidelines

      ea0084ps1-01-04
    • Subacute thyroiditis and COVID-19 vaccination

      ea0084ps1-01-05
    • The peculiarities of the subacute thyroiditis treatment course during the COVID-19

      ea0084ps1-01-06
    • The course and outcome of subacute thyroiditis: A retrospective analysis and predictive model

      ea0084ps1-01-07
    • Graves' orbitopathy and subacute thyroiditis related to SARS-CoV-2 infection or vaccination: the experience of a single centre in milan, italy

      ea0084ps1-01-08
    • Subacute thyroiditis after SARS-CoV-2 vaccine

      ea0084ps1-01-09
  • Hypothyroidism
  • • Modern study of life quality of women with subclinical hypothyroidism

      ea0084ps1-02-10
    • Ventricular extrasystoles as a consequence of hypothyroidism

      ea0084ps1-02-11
    • Characteristics of specialists delivering clinical care for hypothyroidism in eupope: the [ldquo]THESIS[rdquo] study (treatment of hypothyroidism in europe by specialists: an international survey)

      ea0084ps1-02-12
    • Sex hormones levels and chronic autoimmune thyroiditis in a cohort of obese male patients

      ea0084ps1-02-13
    • A case of late-onset dyshormonogenic goiter with hypothyroidism due to a homozygous mutation of SLC26A7 gene

      ea0084ps1-02-14
    • Use of iodine in the treatment of congenital hypothyroidism with an in situ thyroid gland and of non-autoimmune subclinical hypothyroidism

      ea0084ps1-02-15
    • Evolution of congenital hypothyroidism with in situ thyroid gland in children and adolescents: Clinical and biochemical features at diagnosis and after retesting

      ea0084ps1-02-16
    • Isolated hypothyroxinemia - not only in pregnancy

      ea0084ps1-02-17
    • Human cerebral organoids as in vitro platform to assess thyroid hormone system disrupting chemicals

      ea0084ps1-02-18
  • Thyroid Cancer CLINICAL 1
  • • Is isthmic tumor location in papillary thyroid carcinoma a high-risk factor in comparison with tumor located in thyroid lobes?

      ea0084ps1-03-19
    • Changes in clinical status after second 131I treatment in patients with differentiated thyroid cancer (dtc) not cured with the initial treatment

      ea0084ps1-03-20
    • Risk of structural recurrence in differentiated thyroid carcinoma (DTC) patients without evidence of disease after initial treatment: insights into risk factors and comparison with american thyroid association guidelines

      ea0084ps1-03-21
    • Low risk differentiated thyroid carcinoma (DTC) can be safely treated with thyroidectomy alone: real-life experience in a medium-long term follow-up

      ea0084ps1-03-22
    • Comparison between minimal and gross ete for risk of recurrence in papillary thyroid carcinoma : a propensity score matching study

      ea0084ps1-03-23
    • Central lymph node ratio predicts prognosis of N1B papillary thyroid cancer

      ea0084ps1-03-24
    • Low-intermediate risk thyroid cancer: no benefit of postsurgical iodine?

      ea0084ps1-03-25
    • Age as a prognostic factor in ata low and intermediate risk thyroid cancer patients

      ea0084ps1-03-26
    • Clinical significance and prognosis of solid / trabecular component areas of papillary thyroid carcinoma

      ea0084ps1-03-27
    • Cardiometabolic risk factors in a cohort of algerian thyroid cancer survivals

      ea0084ps1-03-28
  • Thyroid Hormone Transporters and Development
  • • Cell-specific function of the thyroid hormone transporters MCT8 and oatp1c1 in murine brain barrier cells

      ea0084ps1-04-29
    • Impact of thyroid hormone transport on the hippocampal gabaergic and glutamatergic system

      ea0084ps1-04-30
    • The role of type 3 deiodinase in a human model for early brain development

      ea0084ps1-04-31
    • Three-dimensional spheroids: a new approach for the identification and characterization of novel markers for tumor-initiating cells subpopulations in thyroid cancer

      ea0084ps1-04-32
    • Transcriptomic signature of human embryonic thyroid reveals transition from differentiation to functional maturation

      ea0084ps1-04-33
    • The dawning of deiodinases: an outer ring deiodinase activity in the social amoeba dictyostelium discoideum with high affinity for reverse t3

      ea0084ps1-04-34
    • Spatiotemporal expression of the thyroid hormone transporter MCT8 during cortical neurogenesis in human cerebral organoids

      ea0084ps1-04-35
    • Thyroid hormone signaling in a human cellular model for early brain development

      ea0084ps1-04-36
  • Miscellaneous
  • • The sollid study (simplification of low level internal dosimetry): preliminary findings

      ea0084ps1-05-37
    • TSH is superior to T4 for the assessment of thyroid function

      ea0084ps1-05-38
    • The effect of obesity-related allostatic changes on cardio-metabolic risk in euthyroid children

      ea0084ps1-05-39
    • Thyroid hormone variability and cardiovascular morbidity in hyperthyroid patients treated with long-term antithyroid drug therapy

      ea0084ps1-05-40
    • I-131 treatment of patients with autonomously functioning thyroid nodules and normal TSH blood level

      ea0084ps1-05-41
    • Not all automated FT4 immunoassays measure accurately in samples of pregnant women and hemodialysis patients

      ea0084ps1-05-42
    • Treatment of hyperthyroidism reduces the systemic oxidative stress load, as measured by biomarkers of rna and dna damage

      ea0084ps1-05-43
    • The effect of testosterone supplementation on the hpt axis in euthyroid hypogonadal adult men: a prospective observational study

      ea0084ps1-05-44
    • Abstract unavailable

      ea0084ps1-05-45
    • Body composition determinants of thyroid function and volume in euthyroid patient with obesity

      ea0084ps1-05-46
  • Hypothyroidism Treatment
  • • Prescription of levothyroxine and concurrent use of anti-arrhythmic and bone-anti-resorptive drugs in belgium: retrospective study in a large population sample

      ea0084ps2-06-47
    • Pseudomalabsorption of levothyroxine: munchausen's syndrome, compliance defects or fraud?

      ea0084ps2-06-48
    • Faecal microbiota composition in patients with increased need of levothyroxine

      ea0084ps2-06-49
    • TSH levels assessment in hypothyroid patients treated with liquid or tablet l-thyroxine

      ea0084ps2-06-50
    • Abstract unavailable

      ea0084ps2-06-51
    • The effect on serum tsh levels in patients in treatment with proton pump inhibitors after the switch from oral L-T4 tablet to a liquid L-T4 formulation

      ea0084ps2-06-52
    • Whole-body oxidative stress measured by biomarkers of RNA and DNA damage is higher in hypothyroid women, even after treatment, than in healthy individuals, measured by biomarkers of RNA and DNA damage

      ea0084ps2-06-53
    • Treatment of hypothyroidism in europe by specialists: an international survey (THESIS): analysis of contested indications for prescribing among uk participants

      ea0084ps2-06-54
    • Free T3 levels and clinical status of patients with levothyroxine-compensated primary hypothyroidism: can we do better?

      ea0084ps2-06-55
    • Polychlorinated biphenyl congeners PCB 118 and PCB 126 induce upregulation PD-L1 expression in human thyrocytes through aryl hydrocarbon receptor (AHR) pathways

      ea0084ps2-06-56
  • Graves’ Disease 1
  • • Post-alemtuzumab graves' disease remitting after switch to ocrelizumab

      ea0084ps2-07-57
    • High IGG4 serum levels in graves' disease compared with nonautoimmune hyperthyroidism

      ea0084ps2-07-58
    • TPO antibody status prior to first radioactive iodine therapy as a predictive parameter for early hypothyroidism in graves' disease

      ea0084ps2-07-59
    • Polymorphisms in proinflammatory cytokines' genes and lipid profile in patients with graves' disease

      ea0084ps2-07-60
    • Management of graves' disease among endocrinologists in russia

      ea0084ps2-07-61
    • Multifocality in sporadic and familiar medullary thyroid cancer: analysis of prevalence and possible predictive roles

      ea0084ps2-07-62
    • Corticosteroids and mycophenolic acid have a synergistic effect on chemokines secretion in orbital cells from patients with graves' ophthalmopathy

      ea0084ps2-07-63
    • The effect of glucocorticoids on hyaluronan production of orbital fibroblasts

      ea0084ps2-07-64
    • Hyperthyroidism in graves' disease and subacute thyroiditis and association with cardiovascular events

      ea0084ps2-07-65
    • Influence of thyroperoxydase and thyroglobulin antibodies on the presentation and the evolution of medically treated graves' disease

      ea0084ps2-07-66
  • Thyroid Cancer BASIC
  • • Down-regulated HSA-MIR-204-3p may identify high-risk papillary thyroid carcinoma patients

      ea0084ps2-08-67
    • NOX-derived oxidative stress is high in neoplastic thyroid lesions and correlates with ata risk in papillary thyroid cancer

      ea0084ps2-08-68
    • Use of long noncoding rnas for molecular diagnosis of thyroid cancer

      ea0084ps2-08-69
    • Biochemical and clinical characteristics of 16 belgian families with germline insttctdelg mutation affecting codon 666 of the retgene: a retrospective cohort study

      ea0084ps2-08-70
    • Stabilin-1 Macrophages in thyroid cancer microenvironment

      ea0084ps2-08-71
    • The extracellular matrix actively influence thyroid cancer cells sensitivity to TKIS

      ea0084ps2-08-72
    • MiR-145 and miR7 as а potential diagnostic markers of thyroid cancer

      ea0084ps2-08-73
    • EIF1AX gene variants in the context of thyroid tumorigenesis

      ea0084ps2-08-74
    • PD-L1 and MCL-1 markers and the relationship with prognostic characteristics of differentiated thyroid carcinoma

      ea0084ps2-08-75
    • Double mutation of the TERT promoter in extremely aggressive papillary thyroid carcinoma

      ea0084ps2-08-76
  • Thyroid Hormone ACTION
  • • Correlation between plasmatic long pentraxin PTX3 and nodular thyroid disease: a preliminary report

      ea0084ps2-09-77
    • Synthetic analogs of 3-iodothyronamine (T1AM) prevent [beta]-amyloid neurotoxicity in an in vitro model of alzheimer's disease (AD)

      ea0084ps2-09-78
    • Ectopic expression of human TRA and TRB mutants disentangle the isoform-specific regulation of gene expression during zebrafish development

      ea0084ps2-09-79
    • Deiodinase type I (DIO1) regulation in non-alcoholic fatty liver disease (NAFLD)

      ea0084ps2-09-80
    • An experimental framework for probing molecular mechanisms of local thyroid hormone action during cortical neurogenesis in human cerebral organoids

      ea0084ps2-09-81
    • Novel central actions of thyroid hormone in the control of body temperature

      ea0084ps2-09-82
    • FAM83B is involved in thyroid cancer cell differentiation and migration

      ea0084ps2-09-83
    • Molecular mechanisms underlying action of triac in resistance to thyroid hormone BETA (RTH[beta])

      ea0084ps2-09-84
    • 3-Iodothyroacetic acid release in a mouse model of ischemia-induced synaptic dysfunction

      ea0084ps2-09-85
    • Quantification of CD5L as circulating marker of peripheral thyroid hormone action

      ea0084ps2-09-86
  • Nodules & Cancer
  • • Toetva- scarless thyroid surgery in hungary

      ea0084ps2-10-87
    • Neoadjuvant effects of apatinib in progressive, metastatic differentiated thyroid cancer (DTC)

      ea0084ps2-10-88
    • Follicular thyroid neoplasm with papillary-like nuclear features (NIFT-P) showed peculiar ultrasonographic features compared to follicular variant of papillary thyroid carcinoma (FV-PTC), follicular carcinoma (FTC) and follicular adenoma (FA)

      ea0084ps2-10-89
    • Abstract unavailable

      ea0084ps2-10-90
    • Comparison of the clinicopathological features and oncologic outcomes of the classic papillary thyroid carcinoma with tall cell features and tall cell variant

      ea0084ps2-10-91
    • Incidence of non-diagnostic and undetermined cytologies in ultrasound-guided fine needle aspiration biopsy specimens of thyroid nodules - a single-center cohort

      ea0084ps2-10-92
    • Elastography in the assessment of cold solid thyroid nodules

      ea0084ps2-10-93
    • Follow-up and incidence of malignancy in eu-tirads 3 nodules with indication of fine needle aspiration cytology. a single-center descriptive study

      ea0084ps2-10-94
    • Contribution of cyto-histological genetic profile to a precocious diagnosis in thyroid neoplasm

      ea0084ps2-10-95
    • Prospective, observational study on radioiodine treatment in DTC patients with intermediate RISK or micro lymph node metastases

      ea0084ps2-10-96
  • Case Reports
  • • Van wyk-grumbach syndrome: an unusual presentation of long-standing primary hypothyroidism mimicking ovarian tumor

      ea0084ps3-11-97
    • Complicated treatment with lenvatinib for hurthle cell carcinoma

      ea0084ps3-11-98
    • The clinical outcome of covid-19 infection in a patient with the history of multinodular goiter: case report

      ea0084ps3-11-99
    • Differentiation of parathyroid gland from a lymph node in clinical practice

      ea0084ps3-11-100
    • Carpal Tunnel Syndrome in Subclinical Hypothyreosis

      ea0084ps3-11-101
    • Do not rush to overdiagnose when a newly formed node is detected

      ea0084ps3-11-102
    • Suspicious thyroid nodule in de quervain's thyroiditis

      ea0084ps3-11-103
    • Parathyroid adenoma apoplexy mimicking a thyroid bleeding cyst, a seemingly innocent condition may harbor a threatening one

      ea0084ps3-11-104
    • Pseudomalabsorption of levothyroxine

      ea0084ps3-11-105
  • Graves’ Disease 2 and Orbitopathy
  • • Alterations in the gut microbiota are associated with the humoral immune response in graves' disease

      ea0084ps3-12-106
    • Macrophage-orbital fibroblasts interaction in context of hypoxic signaling for inflammatory processes during graves' orbitopathy

      ea0084ps3-12-107
    • The incidence and risk factors of radioiodine-induced graves' disease following treatment of thyroid autonomous tissue

      ea0084ps3-12-108
    • Blocking the TSH receptor with human monoclonal autoantibody K1-70TM in patients with graves' disease - results from a phase 1 clinical trial

      ea0084ps3-12-109
    • Linear mixed model analysis of quality of life scores in patients with thyroid eye disease treated with teprotumumab from three 24-week clinical trials

      ea0084ps3-12-110
    • Circulating marginal zone b cells and IGA serum levels as potential biomarkers of clinical activity of graves' orbitopathy

      ea0084ps3-12-111
    • Alemtuzumab-induced graves' orbitopathy successfully treated with a single dose of rituximab

      ea0084ps3-12-112
    • Temporal trends in the clinical presentation of graves' ophthalmopathy: a single - centre retrospective study

      ea0084ps3-12-113
  • Pregnancy & Iodine
  • • The troubled discourse of hypothyroidism in pregnancy: sentiment analysis of the literature from 2011 to 2021

      ea0084ps3-13-114
    • Higher thyroid FT3-to-FT4 ratio is associated with gestational diabetes mellitus and adverse pregnancy outcomes

      ea0084ps3-13-115
    • Iodine status in danish pregnant women after an increase in iodine fortification: a regional study

      ea0084ps3-13-116
    • Iodine status during pregnancy in the veneto region: impact on maternal and newborn thyroid function and analysis of the nutritional and socio-economic determinants

      ea0084ps3-13-117
    • Which is the best pre-conceptional TSH cut-off in women submitted to assisted reproductive technology?

      ea0084ps3-13-118
    • The impact of iodine supplementation in pregnancy on iodine intake, thyroid function and thyroid volume in pregnant women from iodine sufficient region

      ea0084ps3-13-119
    • The impact of thyroid function on neonatal outcome in women with polycystic ovary syndrome treated with metformin or placebo during pregnancy

      ea0084ps3-13-120
    • Thyroid homeostasis in iodine deficient healthy pregnant women from 10 villages of bihar, india

      ea0084ps3-13-121
    • Preconception tsh levels and early gestation maternal thyroid function in a large cohort of women with hashimoto's thyroiditis (ht) diagnosed preconceptionally

      ea0084ps3-13-122
  • Thyroid Cancer CLINICAL 2
  • • A case of warthin-like papillary thyroid cancer. surgical decision based on eu-tirads criteria

      ea0084ps3-14-123
    • Evaluating prognostic markers for stage migration in medullary thyroid cancer

      ea0084ps3-14-124
    • Lymph nodes metastases in differentiated thyroid cancer patients: understanding their impact on the clinical outcome

      ea0084ps3-14-125
    • The prognostic role of chromosomal gains and loss in sporadic medullary thyroid carcinoma

      ea0084ps3-14-126
    • Dominant benign thyroid nodules (BTN) treated with percutaneous microwave termoablation (PMWT): an effective tool to decrease thyroid nodule volume

      ea0084ps3-14-127
    • Progrp as an additional screening marker in the diagnostic work up for medullary thyroid carcinoma

      ea0084ps3-14-128
    • Hypocalcaemia secondary to lenvatinib induced-hypoparathyroidism: a case-report

      ea0084ps3-14-129
    • The role of calcitonin wash-out in the diagnosis of small sporadic medullary cancer - case reports

      ea0084ps3-14-130
    • Somatic BRAF V600E mutation in a patient with medullary thyroid carcinoma

      ea0084ps3-14-131
    • Efficacy and safety of lenvatinib in a cohort of well-differentiated advanced thyroid carcinomas

      ea0084ps3-14-132
  • Thyroid Cancer Diagnosis & Treatment
  • • European thyroid association guideline on the management of pediatric thyroid nodules and thyroid carcinoma

      ea0084ps3-15-133
    • Patient-reported outcomes (PROS) from patients with RET-mutant medullary thyroid cancer (MTC) and ret fusion-positive TC treated with pralsetinib in the arrow trial

      ea0084ps3-15-134
    • Clinical relevance of lower titer thyroglobulin (TG) autoantibodies in patients with differentiated thyroid carcinoma

      ea0084ps3-15-135
    • The role of core needle biopsy in the diagnosis of primary thyroid lymphoma and anaplastic thyroid carcinoma: a systematic review and meta-analysis

      ea0084ps3-15-136
    • Tendency of progression of antithyroglobulin antibody as a predictor of prognosis in patients with papillary thyroid carcinoma

      ea0084ps3-15-137
    • Routine molecular analysis of fine-needle aspiration biopsies of thyroid nodules

      ea0084ps3-15-138
    • Thyroid lymphoma - lessons learned when time is of the essence

      ea0084ps3-15-139
    • Basal calcitonin as guide for an early and safe thyroid surgery in RET gene carriers

      ea0084ps3-15-140
    • What do different echogenic micro-foci in papillary thyroid carcinoma nodules and metastatic lymph nodes represent in histopathology?

      ea0084ps3-15-141